Results 101 to 110 of about 3,437 (155)

Evolving dynamics of H5Nx avian influenza in China revealed by long-term wild bird surveillance. [PDF]

Nat Commun
Li X, Lv X, Li Y, Fei M, Zhang S, An Q, Qin S, Peng P, Li J, Liang H, Xiu Y, Li Z, Wang Y, Wang Y, Zeng X, Hou Z, Sun H, Xu Y, Li Y, Chai H.   +19 more
europepmc   +1 more source

Circulation of avian influenza viruses in migratory birds in Europe and in Africa: a systematic review. [PDF]

Emerg Microbes Infect
Defaye B, Lamarque M, Moreau J, Gelle T, Imbert C, Malvy D, Delhaes L, Mercier A, Hantz S, on the behalf of the EMERG Consortium.   +9 more
europepmc   +1 more source

Development, Immunogenicity and Protective Efficacy of an Associated Inactivated Vaccine Against Highly Pathogenic Avian Influenza and Newcastle Disease in Chickens. [PDF]

Vaccines (Basel)
Myrzakhmetov Y, Assanzhanova N, Ryskeldinova S, Mailybayeva A, Sagymbayeva A, Kozhamkulov Y, Yamanova E, Sidikhov R, Kozhabergenov NS, Usserbayev B, Zhekebekov K, Nurabayev S, Zhugunissov K, Akmyrzayev N.   +13 more
europepmc   +1 more source

Emerged N193S mutation of PA-X protein disabled the immunity of mucosal dendritic cells for regulating virulence of clade 2.3.4.4b H5 subtype virus. [PDF]

Emerg Microbes Infect
Miao X, Xu X, Han Y, Wang Y, Wang W, Wang J, Yin Y, Chen S, Peng D, Qin T.   +9 more
europepmc   +1 more source

Trimeric hemagglutinin vaccine provides chickens complete protection against lethal H5 subtype avian influenza virus from clade 2.3.4.4b. [PDF]

Emerg Microbes Infect
Chen T, Huang Q, Chen X, Zhu J, Kong D, Liao X, Liao M, Fan H.   +7 more
europepmc   +1 more source

Protective Efficacy Evaluation of Various Inactivated Vaccines Against the Newly Circulated Highly Pathogenic Avian Influenza Virus H5N1 of Clade 2.3.4.4b in Pekin Ducks. [PDF]

Viruses
Shosha EAEM, Eldaghayes I, Ali AAH, Senosy Ali W, Elhayani EH.   +4 more
europepmc   +1 more source

MF59-adjuvanted A/Astrakhan influenza vaccine induces cross-neutralizing H5N1 antibodies in ferrets against circulating clade 2.3.4.4b viruses. [PDF]

NPJ Vaccines
Segovia K, Rathnasinghe R, Patton C, Kwon B, Longstaff RA, Hofmann D, Banger KK, Xu H, Lacey M, Settembre E, Palladino G, Kennedy AT, Music N.   +12 more
europepmc   +1 more source

Investigation and impact of mammalian adaptation markers on H5N8 high pathogenicity avian influenza polymerase activity. [PDF]

Npj Viruses
Fusade-Boyer M, Kocher A, Bessière P, Figueroa T, Foret-Lucas C, Vergne T, Chevalier C, Ducatez MF, Volmer R.   +8 more
europepmc   +1 more source

A Phase 1/2 Dose-Ranging Safety and Immunogenicity Study of mRNA-Based Candidate Pandemic Influenza Vaccines in Healthy Adults. [PDF]

Clin Infect Dis
Cosgrove CA, Avanesov A, Rust D, Osibajo S, Kang K, Leav B, ODYSSEY Study Group .   +6 more
europepmc   +1 more source

Marked Antigenic Divergence and Evolutionary Analysis of H5 AIVs from Wild Birds in East China, 2013-2022. [PDF]

Animals (Basel)
Su X, Cai K, Zong Y, Guo Y, Yin Y, Zheng X, Miao X, Yang H, Qin T, Peng D, Chen S.   +10 more
europepmc   +1 more source